BiondVax Pharmaceuticals Ltd. Gains 97.3%
Wed, Dec 22, 2021 at 05:33 PM
BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ) jumped higher at $2.92, a gain of 97.3%. On Tue, Dec 21, 2021, BVXV:NASDAQ hit a New 2-Week Intraday Low of $1.41. The stock appeared on our News Catalysts scanner on Wed, Dec 22, 2021 at 04:31 PM in the 'MISCELLANEOUS' category. From Tue, Dec 07, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Jul 28, 2021 at $4.19 with a volume of 14M+.
About BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ)
BiondVax Pharmaceuticals Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.
Top 10 Gainers:
- BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ), 97.3%
- SOPA (SOPA:NASDAQ), 53.43%
- Acasti Pharma Inc. (ACST:NASDAQ), 52.25%
- ENSC (ENSC:NASDAQ), 49.38%
- ALJ Regional Holdings, Inc. (ALJJ:NASDAQ), 48.31%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 34.41%
- Nxt-ID, Inc. (NXTD:NASDAQ), 28.35%
- GET (GET:NASDAQ), 26.5%
- SSU (SSU:NYSE), 24.5%
- IINN (IINN:NASDAQ), 23.67%